PresentationsVideo ProMIS Neurosciences: “Best in Class” therapy for misfolded protein diseases, based on a proprietary discovery platformJohanne…Promis Neuro AdminNovember 6, 2019
Presentations Executive Chairman Gene William’s Presentation at the HC Wainwright Investor ConferenceSeptember…Promis Neuro AdminSeptember 10, 2019
Presentations CSO Neil Cashman’s overview of ProMIS’ unique capability to selectively target toxic, misfolded proteins that are root causes of neurodegenerative diseasesView…Promis Neuro AdminAugust 12, 2019
PresentationsVideo Dr. James Kupiec’s update from AAIC 2019: Demonstrating Early Proof-of-Concept with Biomarkers and Focused Patient PopulationsView…Promis Neuro AdminAugust 6, 2019
NewsPresentationsVideo ProMIS Neurosciences Highlights Data for PMN310 at AAIC 2019 Alzheimer’s…Promis Neuro AdminJuly 18, 2019